baber/WOPTO huggingface dataset:
Patent CA-2881905-A1 (CA)
Title: Circuit arrangement and method of operating a circuit arrangement
Inventor: SAFAEE ALIREZA
IPC: B60L11/18
Filed: 2013-09-10
Abstract: The invention relates to a circuit arrangement of an electric vehicle, in particular a circuit arrangement (11) of an electric vehicle for inductive power transfer to the vehicle, and a method of operating the named circuit arrangement, wherein the circuit arrangement (11) comprises an impedance (IM1, IM2, IM3 ) and at least one rectifier (6) for rectifying an AC voltage, wherein an AC part (4) of the circuit arrangement (11) comprises the impedance (IM1, IM2, IM3), wherein the rectifier (6) connects the AC part (4) to a DC part (5) of the circuit arrangement (11), wherein the circuit arrangement (11) further comprises at least one current control means for controlling a current flow in the AC part (4) as well as to a method of manufacturing a circuit arrangement of an electric vehicle and to an electric vehicle.
Patent CA-2883026-A1 (CA)
Inventor: RICHTHAMMER BURKHARD
IPC: B60L50/10
Filed: 2015-02-24
Abstract: Il est décrit une machine de travail, plus particulièrement prenant la forme dun camion à benne ou dun camion, doté dun mécanisme de traction diesel-électrique, comprenant au moins un moteur à combustion interne, au moins un alternateur et au moins un ensemble délectronique de puissance, ainsi quau moins un moteur électrique dans lequel lélectronique de puissance est divisée en modules fonctionnels et dans lequel au moins un, préférablement chaque, module fonctionnel a un logement enveloppé.
Patent CA-2885033-A1 (CA)
Inventor: NORD DUSTIN P
IPC: F15D1/02
Filed: 2013-09-21
Abstract: The present invention relates to a method and a device comprising a self- regulating pressure pipe for increasing a rate of a fluid flow of a fluid and configured to respond to the volume of the fluid or the viscosity of the fluid by decreasing or increasing the pressure within the self-regulating pressure pipe.
Patent CA-2886720-A1 (CA)
Inventor: MORRIS IAN
IPC: F17D1/04
Filed: 2015-04-01
Abstract: This invention relates to a method of moving natural gas mixes directly from a high pressure pipeline into a marine or similar liquid containment or transport system. During the loading process a select rich natural gas mixture is transformed into a liquid state without the need for an intermediate traditional LNG processing facility. The liquid mixture results from an induced phase change caused by releasing high pressure NGL enriched natural gas from a pipeline or storage into a lower pressure containment system. The pressures of adjacent gas pipelines are utilized to assist with loading and unloading the stored liquid. Increase in constituent NGLs, chilling or pressurizing can further increase the desired liquid storage density. The work expands beyond existing teachings of the authors and others. The density of the natural gas component held in the liquid here exceeds those of PLNG or CNG  under these selected conditions.
Patent CA-2887085-A1 (CA)
Inventor: CAWELLO WILLI
IPC: A61K9/70
Filed: 2013-11-21
Abstract: The present invention relates to a transdermal therapeutic system, comprising (a) a backing layer, (b) a solvent -based self-adhesive matrix layer containing rotigotine as active ingredient, and (c) a release liner, wherein the self- adhesive matrix layer has a coating weight of about 75-400 g/m2 and comprises a reservoir layer containing about 9-25 wt.-% rotigotine based on the weight of the reservoir layer, a kit comprising two transdermal therapeutic systems of the present invention as well as a method for the preparation of the transdermal therapeutic system of the present invention. In addition, the present invention relates to a transdermal therapeutic system comprising rotigotine as active ingredient for use in the treatment of patients suffering from Parkinson's disease, Parkinson's plus syndrome, depression, fibromyalgia and the restless-legs syndrome and for use in the treatment or prevention of dopaminergic neuron loss or cognitive disorders by transdermal administration of rotigotine once or twice weekly, wherein the transdermal therapeutic system comprises a backing layer, a solvent -based rotigotine containing self-adhesive matrix layer as well as a release liner and is adapted to allow for the transdermal administration of therapeutically effective amounts of rotigotine for at least 3 days.
Patent CA-2887302-A1 (CA)
Inventor: SANFORD LINDSAY N
IPC: C12Q3/00
Filed: 2013-10-08
Abstract: Systems, methods, and kits are provided wherein a temperature-sensitive reagent that emits a luminescent signal is used to adjust the identification of the temperature of a sample or to control thermocycling. In various illustrative embodiments, the sample is a PCR mixture.
Patent CA-2890722-A1 (CA)
Inventor: AAMER KHALED ABDEL-HAKIM HELMY
IPC: C08J5/18
Filed: 2015-05-08
Abstract: Disclosed are self-assembled structures prepared from block copolymers, for example, diblock copolymers of the formula (I): (see formula I) wherein R1-R4, n, and m are as described herein, which find use in preparing nanoporous membranes. In an embodiment, the block copolymer self-assembles into a cylindrical morphology. Also disclosed is a method of preparing such self-assembled structures which involves spin coating a polymer solution containing the block copolymer to obtain a thin film, followed by solvent annealing of the film. Further disclosed is a method of preparing porous membranes from the self-assembled structures.
Patent CA-2892804-A1 (CA)
Inventor: BRAY ROBERT REGINALD
IPC: B64C3/14
Filed: 2013-11-25
Abstract: The present disclosure relates to a wing. More specifically, aspects of the invention relate to a variable shaped wing movable incrementally between a neutral configuration and a deformed configuration, wherein the wing takes a reflexed camber aerofoil section shape in the deformed configuration. The wing includes a first aerofoil segment and a second aerofoil segment having ends connected or fixed to one another at opposing neutral leading and trailing edges and spaced apart from one another along their lengths across a neutral mean camber line extending between the neutral leading and trailing edges to form a neutral aerofoil section of the wing. One or more actuators deform the wing between the neutral aerofoil section and a reflexed camber aerofoil section, with the first and second aerofoil segments being resilient to bias the wing towards an initial at rest aerofoil section.
Patent CA-2893608-A1 (CA)
Inventor: ROE DONALD CARROLL
IPC: A61F13/49
Filed: 2013-12-05
Abstract: The present disclosure is directed, in part, to an absorbent article comprising an absorbent core disposed at least partially intermediate the topsheet and the backsheet and comprising a core wrap enclosing an absorbent material. The core wrap comprises a first material and a second material. The first material forms a C-wrap at least partially around the second material. The absorbent material comprises at least 80% of superabsorbent polymers by weight of the absorbent material. The absorbent core comprises a channel substantially free of the superabsorbent polymers and at least partially oriented in a longitudinal direction of the article. The channel has an arcuate portion facing a longitudinal axis of the article. An angle between a tangent line of the arcuate portion and the longitudinal axis is greater than or equal to 20 degrees.
Patent CA-2894814-A1 (CA)
Inventor: KORUS MICHAEL F
IPC: H04W72/00
Filed: 2013-11-26
Abstract: A method and apparatus for assigning Multimedia Broadcast Multicast Service (E-MBMS) bearers in at least two Multimedia Broadcast Single Frequency Network (MBSFN) areas in a 3GPP compliant wireless communication system is provided. An infrastructure device receives identifiers of a primary preferred MBSFN area and a secondary preferred MBSFN area from a User Equipment (UE). The infrastructure device assigns a first E-MBMS bearer in a first MBSFN and a second E-MBMS bearer in a second MBSFN, to support a call to the UE, the first and second E-MBMS bearers providing the same media transmission to the UE as part of a group call. The infrastructure device may receive an attribute parameter comprising a request for Make Before Break service or a request for a boost to coverage, from the UE.
Patent CA-2895007-A1 (CA)
Inventor: TINGLEY WILLIAM Q III
IPC: B23D1/08
Filed: 2015-06-19
Abstract: A non-spindle multi-axis machining center (600) and method for forming a part using a non-rotating cutting tool (400) for removing material from a non- rotating workpiece within a three-dimensional work envelope. The non-spindle machining center makes obsolete the use of mills for profiling operations without the need to rotate the cutting tool to produce sufficient torque to remove material. Instead, the cutting tool (400) applies a linear cutting force to the workpiece along a one-, two-, or three-dimensional cutting path with sufficient impact to remove material by means of controlled fracturing instead of plastic deformation. Also, without the need to rotate, neither the cutting tool nor the part are constrained in shape by axial symmetry. Therefore, parts without restrictions in shape can be produced with higher material removal rates and finer surface finishes than by milling or turning.
Patent CA-2895590-A1 (CA)
Inventor: WILLAND NICOLAS
IPC: C07D498/10
Filed: 2013-12-20
Abstract: The present invention concerns a spiroisoxazoline compound of general formula (I): in which m and n are 0 or 1, R1 represents, inter alia, an optionally substituted alkyl chain, in particular substituted with fluorine or with a cyclic group, and R2 is chosen from phenyl and optionally substituted benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and the heterocycles having 5 or 6 vertices comprising at least one atom chosen from S, N and O. The present invention also concerns the use of this compound as a drug, in particular in the treatment of bacterial and mycobacterial infections such as tuberculosis in combination with an antibiotic that is active against bacteria and/or mycobacteria, said compound potentiating the activity of said antibiotic.
Patent CA-2896353-A1 (CA)
Title: Medication cabinet with drawer for selectable access
Inventor: BIBA SCOTT I
IPC: A47B67/02
Filed: 2009-12-23
Abstract: An exemplary embodiment includes a cabinet having at least one drawer with selectable access for storing items, such as medications. A slidable cover with a first opening allows for closure and/or access to items in an interior of the drawer. The cabinet further includes an actuator coupled to the cover and a controller coupled to the actuator to control movement of the first opening relative to the drawer interior in response to signals generated from a user interface.
Patent CA-2896413-A1 (CA)
Inventor: TRIEU VUONG
IPC: A61K39/395
Filed: 2009-12-07
Abstract: The invention provides SPARC and Albumin binding peptides for the targeting of disease sites, such as tumors, with therapeutic and diagnostic agents. In particular, compositions comprising SPARC binding peptide ¨ Antibody Fc domain fusion proteins and methods of their use are disclosed.
Patent CA-2897368-A1 (CA)
Title: Fastening element and syringe
Inventor: ZENKER JOCHEN
IPC: A61M5/34
Filed: 2013-12-10
Abstract: The invention proposes a fastening element for fixing an attachment element to the projection of a syringe or carpule, which projection has at least one protrusion on its outer surface, wherein the fastening element (1) has an annular main body (3) on which an annular element (13) is articulated such that said annular element engages around the projection in an assembled state. The annular element (13) is characterised by: an annular first wall section (15) which is articulated on the main body (3) via a first mounting region (19); and an annular second wall section (17) which is articulated on the first wall section (15) via a second mounting region (21), wherein the two wall regions (15) and (17) are preferably resiliently connected to one another and enclose a free space (23) between them, and wherein the first wall region (15) is connected resiliently to the main body (3).
Patent CA-2897563-A1 (CA)
Title: Mirna-124 as a biomarker
Inventor: TAZI JAMAL
IPC: C12Q1/70
Filed: 2014-01-17
Abstract: A use of at least one miRNA, said at least one miRNA being miR-124, as a biomarker, in particular of a viral infection, or of an efficacy of a therapeutic treatment of said viral infection.
Patent CA-2901776-A1 (CA)
Inventor: RAUCKMAN JAMES B
IPC: A41D19/04
Filed: 2014-02-25
Abstract: A process for producing an electrical rated glove configured to fit the hand of an individual, comprising the steps of making a three dimensional image of the individual's hand; using an appropriately programmed computer to create a three-dimensional model from the image; using the three-dimensional model to create, through the three dimensional printer, a 3-dimensional glove former corresponding to the 3- dimensional image of the wearer's hand; dipping the glover former in a rubber to form a rubber glove on the former corresponding to the shape to the glove former, thus corresponding to the wearer's hand. In another aspect, the process comprises making a three dimensional image of and individual's hand; constructing a mold based upon the three dimensional image of the hand; molding a glove former in the mold; and forming a rubber glove on the glove former.
Patent CA-2901850-A1 (CA)
Inventor: COTE DANA M
IPC: A61B1/32
Filed: 2014-03-17
Abstract: In a first aspect of the subject invention, an iris expander is provided which includes a non-metallic, unitary, multi-segmented body which is expandable from a first state to a second state. The second state defines a larger footprint than the first state with the body being defined by a plurality of segments connected by living hinges. In a further aspect, an iris expander is provided which includes a multi-segmented body that is expandable from a first state to a larger-footprint second state. At least one aperture is formed in the body with a channel extending therefrom embedded in the body such that no portion thereof is exposed externally of the body. The channel is formed to accommodate a portion of an instrument for causing adjustment of the body with avoidance of direct contact of the instrument with the tissue of the iris.
Patent CA-2903995-A1 (CA)
Inventor: BUSKER KAI
IPC: F03D7/02
Filed: 2014-04-04
Abstract: Disclosed is a wind turbine comprising a rotor (106) with at least two rotor blades (108), an electric generator, which is directly or indirectly coupled to the rotor (106) of the wind turbine and generates electric power when the rotor (106) rotates, and a control unit (120) for controlling operation of the wind turbine. The control unit (120) activates a first error operation mode, if parameters of a supply network rise above or fall below a limit value. In the first error operation mode, the control unit (120) is designed to reduce the speed of the rotor (106) to zero and to activate a consumer (400) in order that the consumer (400) consume the electric power generated by the electric generator in the error operation mode.
Patent CA-2904084-A1 (CA)
Title: A process for preparation of (2s, 5r)- sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
Inventor: WANKHEDE KARUNA SURESH
IPC: C07D471/08
Filed: 2013-10-12
Abstract: A process for preparation of (2S, 5R)- Sulfuric acid mono-{[(4- aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester is disclosed which comprises reacting a compound of Formula (II) with a compound of Formula (III) to obtain a compound of Formula (IV).
Patent CA-2908248-A1 (CA)
Title: Pharmaceutical composition for parenteral administration, containing donepezil
Inventor: LEE DEOK KEUN
IPC: A61K9/14
Filed: 2014-04-02
Abstract: The present invention relates to a composition for parenteral administration, containing donepezil as an active ingredient, and a preparation method therefor. Donepezil, which has been conventionally used for oral or transdermal administration, is prepared as microparticles comprising a biodegradable and biocompatible polymer and a release controller so as to be provided as a pharmaceutical composition for sustained release parenteral administration, thereby enabling in vivo sustained release continuously for 2-12 weeks or more. Therefore, it is possible to reduce the frequency of administration to a patient and maintain an effective concentration in the blood for a long time.
Patent CA-2908950-A1 (CA)
Inventor: WALTON ZACHARY W
IPC: E21B33/12
Filed: 2014-02-07
Abstract: A wellbore isolation device comprises: a first layer, wherein the first layer:  (A) comprises a first material; and (B) defines a cavity containing a dissolution medium, wherein a chemical reaction of at least the dissolution medium causes at least a portion of the first material to dissolve. A method of removing the wellbore isolation device comprises: introducing the wellbore isolation device containing the dissolution medium into the wellbore; and allowing the chemical reaction to occur.
Patent CA-2910089-A1 (CA)
Title: Stable curcumin and phospholipid complex with increased bioavailability
Inventor: CAVE HAROLD GORDON
IPC: A61K31/683
Filed: 2013-05-22
Abstract: The present invention relates to a complex, the complex including a phospholipid and curcumin, characterised in that the phospholipid is sourced from a marine oil.
Patent CA-2912034-A1 (CA)
Inventor: FRANK RICHARD
IPC: B60N2/26
Filed: 2015-11-13
Abstract: The child safety seat (1) for use in a vehicle in accordance with the invention comprises a seat member (3) configured to hold a child (2), a base member (4) adapted to be attached to a seat (15) of the vehicle, and a deformable energy absorbing element (20), wherein the seat member (3) is slidably mounted to the base member (4) in such a way that the seat member (3) is displaceable from an initial position to a shifted position by sliding the seat member (3) relative to the base member (4) and in such a way that crash-induced inertial forces acting on the child safety seat (1) during a frontal collision of the vehicle tend to slide the seat member (3) from the initial position to the shifted position, wherein the deformable energy absorbing element (20) is arranged to be deformed when the seat member (3) is slid from the initial position to the shifted position.
Patent CA-2914807-A1 (CA)
Title: Fracturing fluid viscosity-controlling agent in tablet form and containing a polyalkylene oxide and a viscosity reducing agent
Inventor: IDO TORU
IPC: E21B43/26
Filed: 2014-06-09
Abstract: [Problem] To provide: a fracturing fluid viscosity-controlling agent, which is capable of maintaining the high viscosity of the fracturing fluid during fracture formation in hydraulic fracturing and of reducing the viscosity during recovery of the fracturing fluid; a fracturing fluid comprising said viscosity-controlling agent; and a crude oil or natural gas drilling method using said fracturing fluid. [Solution] This viscosity-controlling agent, which is used for controlling viscosity changes of a fracturing fluid used in hydraulic fracturing, comprises polyalkylene oxide and a viscosity-reducing agent and is a tablet.
Patent CA-2916276-A1 (CA)
Inventor: SENEKER CARL
IPC: C09D167/06
Filed: 2014-06-18
Abstract: A coating composition comprising a polyester resin binder and a phosphatized polyester. The compositions are useful for coating containers such as food and beverage containers. The compositions have excellent hydrolytic stability upon storage at high temperature. The compositions are formulated to be substantially free of bisphenol A (BPA) and bisphenol A diglycidyl ether (BADGE).
Patent CA-2918078-A1 (CA)
Inventor: LANGE ETHAN
IPC: F16L3/08
Filed: 2016-01-18
Abstract: Embodiments of the invention provide a clevis hanger system. A clevis top can include a hanging portion, a first leg with a first hole, and a second leg with a second hole. A clevis bottom can include a saddle, a third leg with a third hole, and a fourth leg with a fourth hole. To secure the clevis top to the clevis bottom and define an internal area to receive pipe, the first hole can be aligned with the third hole and the second hole can be aligned with the fourth hole, and a fastener can be received through the first hole, the second hole, the third hole, and the fourth hole. At least one of the first hole and the third hole can be surrounded by a first annular flange.  At least one of the second hole and the fourth hole can be surrounded by a second annular flange.
Patent CA-2919475-A1 (CA)
Inventor: CRAWFORD CHARLES H
IPC: A61M5/145
Filed: 2014-07-10
Abstract: La présente invention concerne un moteur piézoélectrique (150) apte à être réglé dans une plage de fréquences spécifique, qui présente une petite déviation par rapport à une plage de fréquences opérationnelles d'un composant de système d'imagerie à résonance magnétique. Le réglage peut être réalisé de la manière suivante : application d'une pression au moteur piézoélectrique (150), produisant au moins un signal via un tableau de contrôle (200) ; lorsque le signal se trouve à une fréquence sélectionnée dans la plage de fréquences spécifique, application des signaux au moteur piézoélectrique (150) ; mesure d'une fréquence de vibration du moteur piézoélectrique (150) ; et variation de la pression appliquée au moteur piézoélectrique (150). La pression appliquée peut continuer à être réglée jusqu'à ce que la fréquence de vibration mesurée du moteur piézoélectrique (150) se trouve à une fréquence de résonance pour le moteur piézoélectrique (150). Une fois le réglage du moteur piézoélectrique (150) effectué de cette manière, le moteur piézoélectrique (150) peut être incorporé dans un composant de système d'imagerie à résonance magnétique.
Patent CA-2921515-A1 (CA)
Title: Procedes de diagnostic et compositions pour le traitement d'un glioblastome
Inventor: BAIS CARLOS
IPC: C12Q1/68
Filed: 2014-08-29
Abstract: La présente invention concerne des procédés et des compositions pour détecter l'expression d'un ou de plusieurs biomarqueurs afin d'identifier et de traiter des patients présentant des glioblastomes qui sont susceptibles d'être sensibles à la thérapie par antagonistes du VEGF. L'invention concerne également des kits et des articles manufacturés destinés à être utilisés dans les procédés.
Patent CA-2921674-A1 (CA)
Title: Systeme de regulation de temperature corporelle
Inventor: KARMONA ROEE
IPC: F25B21/02
Filed: 2014-11-09
Abstract: L'invention concerne un appareil de régulation de température corporelle comprenant : un récipient comprenant une substance d'absorption de chaleur; un dissipateur thermique en communication avec le récipient; un élément d'isolation thermique relié au récipient; une plaque soutenue sur l'élément d'isolation thermique et conçue pour entrer en contact avec de la peau humaine; un module thermoélectrique relié au dissipateur thermique et à la plaque; un capteur de température relié à la plaque; et une unité de commande configurée pour commander électriquement le module thermoélectrique et le capteur de température.
Patent CA-2924082-A1 (CA)
Inventor: GROOM STUART
IPC: H04M3/42
Filed: 2014-08-21
Abstract: A system and method for mapping a private branch exchange is provided whereby a visual representation of a private branch exchange is graphically displayed. Once the PBX is mapped, a user can then make changes to the connections and other data in the branch exchange and save those changes such that the PBX will then follow the edited structure.
Patent CA-2930035-A1 (CA)
Inventor: VAN NESTE CHARLES WILLIAM
IPC: H02J50/12
Filed: 2014-11-07
Abstract: An electrical source excites a conductive object. A receiver is electrically connected to the object to receive energy from the object, and can power a device. The object can be non-resonant under excitation by the source, and the receiver is excited into resonance by electrical contact with the object. The object can also be resonant under the excitation by the source, and the receiver receives energy from the resonance of the object.